The Wellcome Trust Review 1999 a Selection of Research Projects and Major Initiatives 1 F H !©

Total Page:16

File Type:pdf, Size:1020Kb

The Wellcome Trust Review 1999 a Selection of Research Projects and Major Initiatives 1 F H !© The Wellcome Trust Review 1999 A selection of research projects and major initiatives 1 f H !© The Wellcome Trust Sir Henry Wellcome (1853-1936), the founder of the Wellcome Trust, stated in his will that his The Director charity should support "scientific research which may 3 Changing times Michael Dexter conduce to the improvement of" the physical conditions of mankind".Today, the Trust funds a great diversity of biomedical research in the UK and overseas, SCIENCE FUNDING and supports active programmes in science communication and research in the history of / Viral paralysis medicine.This year©s Wellcome Trust Review samples O Japanese paralytic syndrome just a few of the many excellent projects funded by A new clinical variant of a common viral infection the Trust, and examines how research discoveries Tom Solomon and insights in differing fields can broaden our understanding of the human body in health and disease, an understanding that will underpin the healthcare advances of the next century. JT\ Cell traffic 10 Coats of many colours: Transporting proteins around the cell Margaret S Robinson Thalassaemias 14 In the blood: Thalassaemias in South-East Asia David Weatherall ©A I* 40 ChiChild development I \J HapHappy families?: Non-traditional families and hildren©s well-being Susan Goiombok A A Tuberculosis Bone adaptation II The persistent plague: New strategies for tackling 18 Taking the strain: Bones, exercise and oestrogen tuberculosis Douglas Young Lance Lanyon ©"J "*) Neurodevelopment Segments and eyes: Building the hindbrain and visual system Andrew Lumsden and William Hams Upsetting the balance: Tuberculosis in 48 South Africa Albert Beyers, Paul van He/den ond Nulda Beyers Wound healing r-MEDICINE, SOCIETY AND HISTORY Health scar story: Wound healing and ageing Malaria in East Africa Gillian Ashcmft 54 Roll back malaria: The history of malaria and its control in twentieth-century East Africa Blood pressure Mary \ Dobson, Robert A/I Snow and A pressure situation: The control of blood 32 Maureen J Malowany pressure John Mullins Edinburgh "} / Campylobacter 58 The Trojan horse: The B.ochemical Laboratory The full Campy: The genome of the Royal Infirmary of Edinburgh 1921-1939 sequence of a food-borne Mike Bo/foot, pathogen Julian Forkful/, Chris Lowrence Ban Barrell, Julian Ketley ond Stew Sturdy and Brendan Wren Theatre 62 Staging science: Theatre, debate and schools Peter F/nego/d ©"i v THE DIRECTOR Chan times Medicine and biomedicalresearch are never static. Constant advances in technology and techniques ensure that researchers must adapt to ensure that they stay ahead of the field. That they do so successfully is apparent in the breakthroughs that come every year in our understanding of the human body and of the microorganisms that wage war against our immune systems. This issue of the Wellcome Trust Review covers only a fraction of the Trust-funded research in the UK and overseas, but highlights how modern genetics underpins and drives forward research across a broad span of fields. The genome revolution Only a decade ago, sequencing DNA was a laborious, manual process, and discovering the code tor a single gene was a masterful piece of work. Today, automation and powerful computers have revolutionized the process, enabling the sequences of thousands of genes to be available to all, over the Internet. With the first drafr of the human genome to be completed by spring 2000, and the fine detail by 2003, the next challenge will be to make use of" this vast resource of information. Above: Dr Michael Dexter, Director of the Wellcome Trust. As has been the case in much of biomedicme, research on Left: Segmentation in the microbes is leading the way. The completed genome chick embryo hindbrain. sequence of the bacterium Camfiylobiicter jejtini has brought together six UK groups into a consortium using powerful new techniques to discover why it is a leading cause of food poisoning. In London, Professor Douglas Young is using THE DIRECTOR products of these genes work together to influence the development of such complex systems. Effecting change Despite the efforts of the research and medical communities, problems and pitfalls often arise. In the case of the worldwide eradication campaigns - so successful in removing the scourge of smallpox - little is straightforward. The mass vaccination of children against polio in South- East Asia has not reduced the incidence of paralysis to the extent expected, and Dr Tom Solomon©s work in Vietnam has uncovered a hidden role of Japanese encephalitis virus in such paralysis. In the case of the campaign against malaria. Dr Mary Dobson and colleagues in Oxford and Kenya look back over the last 50 years to ask why the promised eradication has yet to yield results in Africa. Some Above: Mycobocterium luberoilos/s, which causes TB. of the obstacles have been man-made, but most are due to the genome sequence of Mycvbacteriiini tiilwmilmi in the the changing characteristics of the malarial parasite and its search for new vaccines against the bacterium that is the vector, the mosquito. single largest killer in the world today. Such work is key in regions such as the Western Cape Province of South Africa, The structure of society is also undergoing change. With where tuberculosis is rife. Yet the fight against tuberculosis sophisticated technology helping couples with fertility must not focus on the bacterium alone - in the Cape, problems and single or lesbian women to have children, Professor Albert Beyers and colleagues have found that Professor Susan Colombok is investigating the development other factors, such as infection with intestinal parasites, also of children with non-traditional family backgrounds - with reduce the effectiveness of the hodys immune response to encouraging results. At the other end of the age spectrum, M. tuberculosis. diseases of the elderly are becoming more prevalent as the population itself ages. Professor Lance Lanyon and Genetics research is not only about sequence hunting. With colleagues at London LIniversity©s Royal Veterinary College genetic diseases likely to become an increasingly important are investigating how physical strain - such as exercise health burden in the developing world, Professor Sir David helps to strengthen the skeleton and protect against Wcatherall and colleagues at Oxford are investigating the osteoporosis and bone fracture. At Manchester, Dr Gillian frequency and effects on health of the thalassaemias in Ashcrort is looking at the decline in the rate of wound South-East Asia. In Edinburgh meanwhile. Professor lohn healing that comes with old age, often causing chronic Mullins and colleagues are using cutting-edge genetic wounds to develop but, paradoxically, reducing the amount manipulation techniques, allied to classic physiology, to of scarring that results. unravel how the body controls blood pressure. Now and then Cell biology and neuroscicnce have already gained much If the genome revolution is upon us now, an equally from the new technologies of the l l)9()s. The ubiquity of the significant revolution occurred 70 years ago and the face Internet, with its freely available online databases, enabled of medical education and research in the UK universities Dr Margaret Robinson and colleagues at Cambridge to might have looked very different had the events then forge important collaborations with researchers in the USA, transpired differently. Drs Mike Bartoot, Chris Lawrence pushing ahead her research on the transportation systems and Steve Sturdy discuss the role of the Rockefeller inside the cell. The research teams led by Professors Andrew Foundation in the Biochemical Laboratory at the Royal Lumsden and William Harris, examining the development Infirmary of Edinburgh, and the events that helped to of the chick hindbrain and frog eye, respectively, have found bring fully professional academic medicine to the UK. a. plethora or genes involved in each of these most delicate of processes - now the challenge is to determine how the Dr Michael Dexter, Director of the Wellcome Trust 93U TOM SOLOMON The WHO©s programme to eradicate polio by the year 2000 has had Japanese many successes, but there have been difficulties and controversy over the clinical diagnosis of polio. In Vietnam, Dr Tom Solomon and colleagues have paralytic found that many children who were thought to have polio were actually infected with a completely unrelated virus - Japanese encephalitis virus. syndrome A new clinical variant of a common viral infection nthused by the successful eradication of smallpox in the 1970s, in 1988 the World Health Organization E (WHO) embarked upon a global programme to eradicate polio. Polio was considered a suitable target lor eradication because poliovirus is found only in humans, and a cheap and effective vaccine is readily available. Polio viruses infect and destroy nerve cells in the front of the spinal cord (anterior horn cells) that transmit impulses to muscles, making them contract. With the destruction < these anterior horn cells, the muscles are paralysed and become floppy (flaccid) and wasted. Thus polio patients typically suffer from acute flaccid paralysis of the legs ©- and/or arms. The campaign launched by the WHO has consisted, in essence, of mass vaccination (with live oral polio vaccine),1 Anterior and disease surveillance: all new cases of acute flaccid horn cell paralysis are reported, poliomyelitis is diagnosed clinically (motor and then confirmed virologically by culturing the virus neuron) from the stool. Soon after the campaign began there was some controversy, particularly about the clinical diagnosis of polio. Whilst some authorities suggested this was a straightforward diagnosis, others argued that most polio patients may not have polio at all. In Vietnam, where Dr Tom Solomon and colleagues have been studying patients with central nervous system Right: At risk from poliovirus: the anterior horn cells of the spinal cord, which transmit impulses to muscles. Left:The regions affected by Japanese encephalitis virus. infections since 1994, the polio eradication campaign his team had a lucky break.
Recommended publications
  • Annu Al Review
    THE WELLCOME TRUST THE WELLCOME THE WELLCOME TRUST THE WELLCOME TRUST ANNUAL REVIEW ANNUAL REVIEW ANNUAL 1999/2000 1 October 1999 1 October1999 _ 30 September2000 The Wellcome Trust is an independent research-funding charity, established under the will of Sir Henry Wellcome in 1936.It is funded from a private endowment, which is managed with long-term stability and growth in mind. Its mission is to foster and promote research with the aim of improving human and animal health. Its work covers four areas: Knowledge improving our understanding of human and animal biology in health and disease, and of the past and present role of medicine in society. Resources providing exceptional researchers with the infrastructural and career support they need to fulfil their potential. Translation ensuring maximum health benefits are gained from biomedical research. Public engagement raising awareness of the medical, ethical and social implications of biomedical science. CONTENTS Highlights of the year 2 Director’s Introduction 4 Planning for the Future 6 PART 1 MAKING A DIFFERENCE 1999–2000 Knowledge Base 8 Resources 14 Translation 20 Public Engagement 26 PART 2 RESEARCH REPORTS Making faces 32 Tipping the balance 35 Starfish and mousetraps 36 The hidden danger 40 Capping it all 43 Thinking inside the box 44 Why art? 48 The past is before us 50 Birth of a cell 54 Breaking the cycle 57 Cross-talking networks 60 PART 3 A YEAR IN THE TRUST UK Funding 64 Clinical and Careers 66 Centres and Indirectly Managed Major Initiatives 68 International Funding 70 Directly
    [Show full text]
  • Springer A++ Viewer
    PublisherInfo PublisherName : BioMed Central PublisherLocation : London PublisherImprintName : BioMed Central 130591474-760XGenome BiologyGenome BiolLife SciencesAnimal Genetics and GenomicsHuman GeneticsPlant Genetics & GenomicsMicrobial Genetics and GenomicsBioinformaticsEvolutionary BiologyBiomedical and Life Sciences221211343 CoverDate : 2001–12– The Author(s)2001 The genome has landed - let the debate begin ArticleInfo ArticleID : 3976 ArticleDOI : 10.1186/gb-spotlight-20010212-01 ArticleCitationID : spotlight-20010212-01 ArticleSequenceNumber : 47 ArticleCategory : Research news ArticleFirstPage : 1 ArticleLastPage : 2 RegistrationDate : 2001–02–12 ArticleHistory : OnlineDate : 2001–02–12 ArticleCopyright : BioMed Central Ltd2001 ArticleGrants : ArticleContext : 130592211 Pete Moore Email: [email protected] LONDON Sequencing the human genome has been likened to landing on the moon. Two decades ago most people laughed at the prospect. One decade ago the task looked achievable but would be unbelievably slow. Then, a couple of years back we had some 5% of the code and the first draft. In 1998, when Craig Venter set up his own research unit and privatised the sequencing program, he fired a starting pistol. While private investors poured money into Venter's Celera Genomics, governments and the Wellcome Trust were forced to divert streams of cash into the race. The publicly funded Human Genome Project (HGP) was eager to publish a sequence of the genome, and quash any attempt to gain ownership of the information via patenting. The result has been two-fold, says Denis Alexander, head of the Molecular Immunology Programme at the Babraham Institute outside Cambridge, UK. First, having two separate efforts has undeniably accelerated the pace of research, knocking a couple of years off the anticipated time-scale. But second, he like many believes that the high-profile scrap has probably damaged public confidence or public perceptions of science.
    [Show full text]
  • 16233 Wellcomeaw 17-02 27/2/04 10:29 Am Page A1
    16233 WellcomeAW 17-02 27/2/04 10:29 am Page a1 Annual Report and Financial Statements 2003 16233 WellcomeAW 17-02 27/2/04 10:29 am Page a2 a2 Heading to go here strapline to go here if required 16233 WellcomeAW 17-02 27/2/04 10:29 am Page 1 THE WELLCOME TRUST ANNUAL REPORT AND FINANCIAL STATEMENTS 2003 Contents Administrative Details 2 Chairman’s Statement 4 Trustee’s Report 6 Auditors’ Report 15 Consolidated Statement of Financial Activities 16 Consolidated Balance Sheet 17 Statement of Financial Activities of the Trust 18 Balance Sheet of the Trust 19 Consolidated Cash Flow Statement 20 Notes to the Financial Statements 21 Committees of the Board of Governors 49 Board of Governors 50 Executive Management 51 16233 WellcomeAW 17-02 27/2/04 10:29 am Page 2 2 Administrative Details The Wellcome Trust (the ‘Trust’) is a Board of Governors The Wellcome Trust is managed day to day charitable trust created in 1936 by the Will Sir Dominic Cadbury (Chairman) by the Executive Board and other Senior of the late Sir Henry Wellcome and now Management shown as follows: Professor Sir Michael Rutter, CBE, MD, FRS, governed by its Constitution, which was FBA, FMedSci (Deputy Chairman) established in February 2001 by a scheme Executive Board of the Charity Commission.The Trust is Professor Adrian Bird, FRS, FMedSci Dr Mark Walport, PhD, FRCP,FMedSci registered under the Charities Act 1993 Professor Martin Bobrow, CBE, DSc Med, (Director) (from 1 June 2003) (registration number 210183). FMedSci Dr Michael Dexter, DSc, FRS, FMedSci The sole trustee (the ‘Trustee’) is Professor Christopher Edwards, MD, FRSE, (Director) (retired 31 March 2003) The Wellcome Trust Limited, a company FMedSci limited by guarantee (registration number Mrs Linda Arter (Director of Finance and 2711000), whose registered office is Professor Julian Jack, PhD, FRS, FMedSci Information Management) 183 Euston Road, London NW1 2BE.
    [Show full text]
  • Unilateral Visual Loss
    Wellcome Film Project Book of Life: the true wonder emerges Wellcome Trust, 2001 A-Roll interviewees: Isobel and Mark Emms Professor Kay Davies, Head of Human Anatomy and Genetics, University of Oxford Dr Michael Dexter, Director Wellcome Trust, London Sir John Sulston, Director, Sanger Centre Dr Mike Stratton, Head, Human Cancer Genome Project, Sanger Centre Produced by APTN Productions. Colour Duration: 00:12:49:18 00:00:00:00 <Opening titles> <Intertitles> This news feature is brought to you by the Wellcome Trust. It is not part of the regular APTN News Service, but is available free to all broadcasters on the regular news satellite/transponder, for unrestricted use. The Book of Life: The true wonder emerges Following identification by the Human Genome Project of mankind’s genetic code, research papers now reveal the first astonishing overview of how human beings are made. New medical breakthroughs could follow. Created by Wellcome Library, 2009 1 of 9 Available under CC-BY-NC 2.0 UK Wellcome Film Project A-ROLL: 5 mins 19 secs B-ROLL: 6 mins 29 secs> <Opening scene of a physiotherapist lifting a boy, who is wearing leg braces, up from the floor. Physiotherapist speaks> One, two, three, up you go. <Narration over film, unspecified narrator> A physiotherapy session for Theo. He’s a happy six year old but his muscles are weak and wasting away. He has a hereditary disease called spinal muscular atrophy known as SMA. Unless there’s a breakthrough in treatment, he’ll always be in a wheelchair. For his parents there seems little chance of reversing the disease and now that’s changing.
    [Show full text]
  • Nuffield Council on Bioethics Annual Report 2001 Ten Year Anniversary Published by Nuffield Council on Bioethics 28 Bedford Square London WC1B 3JS
    Nuffield Council on Bioethics Annual Report 2001 Ten Year Anniversary Published by Nuffield Council on Bioethics 28 Bedford Square London WC1B 3JS Telephone: +44 (0)20 7681 9619 Fax: +44 (0)20 7637 1712 Email: [email protected] Website: http://www.nuffieldbioethics.org ISBN 1-904384-04-8 November 2002 ©Nuffield Council on Bioethics 2002 All rights reserved. Apart from fair dealing for the purpose of privat study, research, critisim or review, no part of the publication may be produced, stored in a retrieval system or transmitted in any form, or by means without prior permission of the copyright owners. Designed and Printed by dsprint / redesign 020 8805 9585 Foreword was a year of considerable development for the Council. Work gathered pace on 2001three major projects, all of which will be published by mid–2002. Meanwhile, I saw the need to continue to consolidate the funding and organisational structure of the Council. Throughout, I was able to call on the extraordinary generosity of my colleagues on the Council, who gave unstintingly of their time and energy, and on the dedication of the Secretariat. I record here my thanks. The new funding arrangement is a very great The Council’s 10th Anniversary was marked by boost for the Council. It provides stability and a reception. It was a very happy occasion and allows for longer-term planning. I am gave me very great pleasure. It was very extremely grateful to the Council’s three gratifying to be able to thank all those who funders for their encouragement and support. had helped us to chart our path in our first Most critically, the arrangement secures for the decade and to report on our plans and vision Council the continuation of its most prized for the future.
    [Show full text]
  • 6Th International Workshop on the Identification of Transcribed Sequences
    6th International Workshop on the Identification of Transcribed Sequences 6th International Workshop on the Identification of Transcribed Sequences October 3-5, 1996 Edinburgh, Scotland Table of Contents Abstracts of Platform Presentations (arranged by presentation order) Session 1 - Thursday AM, October 3 Session 2 - Thursday PM, October 3 Session 3 - Friday AM, October 4 Session 4 - Friday PM, October 4 Session 5 - Saturday AM, October 5 Poster Presentation Abstracts (arranged by alphabetical order) 1996 Roster of Attendees Abstract Authors (arranged by alphabetical order) Agenda Wednesday October 2, 1996 Sponsors 5:30 pm - 7:30 pm -- Welcoming Reception Cancer Research Campaign Edinburgh Hilton, Pavilion Restaurant European Commission HUGO Europe Lothian and Edinburgh Enterprise Thursday October 3, 1996 U.S. Department of Energy Wellcome Trust 7:30 am - 8:15 am Continental Breakfast, Riverside Suite 8:15 am - Welcome/Opening Remarks Corporate Contributors SESSION 1 - CHAIRS: Yun-Fai Chris Lau and Miriam Amgen Meisler A global biotechnlogy company that discovers, develops, manufactures, and 8:30 am - 8:50 am - James W. Fickett markets human therapeutics based on Transcriptional context from DNA sequence: A advanced cellular and molecular beginning biology. 8:50 am - 9:10 am - Marcelo Bento Soares CIBA-Geigy Subtractive hybridization strategies to facilitate gene CIBA-Geigy are a leading worldwide discovery; Towards the development of libraries biological and chemical group, based Page 1 of 54 6th International Workshop on the Identification of Transcribed Sequences enriched for full-length cDNAs in Switzerland, dedicated to satisfying needs in healthcare, agriculture and 9:10 am - 9:30 am - J. Gregor Sutcliffe industry with innovative value-adding A digital technology for analyzing expression of nearly products and services.
    [Show full text]